Organigram Q3 FY2026 net revenue rises 49% to CAD 105.78 million, driven by Sanity Group contribution, company says
OGI•Net income
Net income was CAD 105.54 million versus a loss of CAD 6.29 million, largely due to a CAD 105.78 million gain on fair value remeasurement of Preferred Shares.
Q3 revenue and segment mix
OrganiGram posted Q3 fiscal 2026 net revenue of CAD 105.78 million, up 49%, driven mainly by medical sales from the Sanity Group acquisition.
- Recreational revenue: CAD 61.82 million
- Medical revenue: CAD 39.03 million
- Wholesale and other revenue: CAD 4.93 million
Margins and adjusted EBITDA
Gross margin before fair value adjustments rose to CAD 38.8 million from CAD 22.42 million; margin expanded to 37% from 32% on the Sanity contribution and domestic efficiencies.
Adjusted EBITDA increased to from , reflecting higher gross margin and the addition of Sanity operations.
